Attenuation of histamine-induced endothelial permeability responses after pacing-induced heart failure: Role for endogenous catecholamines

Microcirculation

Volumn 7, Issue 5, 2000, Pages 307-315

  Dyess, Donna L ^a,b   Hunter, J Leslie ^a   Lakey, James R ^a   Moyer, Darlene ^a   Dougherty, F Carroll ^a   Townsley, Mary I ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Autacoid; Dog; Endothelium; Reflection coefficient; 2 adrenergic antagonist

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; HISTAMINE; ISOPRENALINE;

ANIMAL; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CAPILLARY PERMEABILITY; CONGESTIVE HEART FAILURE; DOG; DRUG EFFECT; METABOLISM; MICROCIRCULATION; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CAPILLARY PERMEABILITY; CATECHOLAMINES; DOGS; ENDOTHELIUM, VASCULAR; HEART FAILURE, CONGESTIVE; HISTAMINE; ISOPROTERENOL; MICROCIRCULATION; PACEMAKER, ARTIFICIAL;

EID: 0034303048     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2000.tb00130.x     Document Type: Article

References (28)

1. Armstrong PW, Stopps TP, Ford SE, DeBold AJ. (1986). Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation 74: 1075-1084.
2. 2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Cardiol 5:430-437.
3. Collins JN, Dyess DL, Ardell JL, Townsley MI, Taylor AE, Ferrara JJ. (1994). The effects of albumin administration on microvascular permeability at the site of burn injury. J Trauma 36:27-33.
4. Dyess DL, Ardell JL, Townsley MI, Taylor AE, Ferrara JJ. (1992). Effects of hypertonic saline and Dextran 70 resuscitation on microvascular permeability after burn. Am J Physiol, 262:H1832-H1837.
5. Grega GJ, Marciniak DL, Jandhyala BS, Raymond RM. (1980). Effects of intravenously infused histamine on canine forelimb transvascular protein efflux following adrenergic receptor blockade. Circ Res 47: 584-591.
6. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. (1986). Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73:615-621.
7. Ishibashi M, Reed RK, Townsley MI, Parker JC, Taylor AE. (1991). Albumin transport across pulmonary capillary-interstitial barrier in anesthetized dogs. J Appl Physiol 70:2104-2110.
8. Ivey CL, Roy BJ, Townsley MI. (1998). Ablation of lung endothelial injury after pacing-induced heart failure is related to alterations in calcium signaling. Am J Physiol 275:H844-H851.
9. Ivey CL, Stephenson AH, Townsley MI. (1998). Involvement of cytochrome P-450 enzyme activity in the control of microvascular permeability in canine lung. Am J Physiol 275:L756-L763.
10. Jacobsen TN, Kassis E, Amtorp O. (1993). Effects of orthostatic stress on peripheral capillary filtration in mild congestive heart failure after healing of myocardial infarction. Am J Cardiol 72:418-422.
11. Kiuchi K, Sato N, Shannon RP, Vatner DE, Morgan K, Vatner SF. (1993). Depressed beta-adrenergic receptor- and endothelium-mediated vasodilation in conscious dogs with heart failure. Circ Res 73:1013-1023.
12. Korthuis RJ, Granger DN, Taylor AE. (1984). A new method for estimating skeletal muscle capillary pressure. Am. J. Physiol. 246:H880-H885.
13. Korthuis RJ, Wang CY, Spielman WS. (1984). Transient effects of histamine on the capillary filtration coefficient. Microvas Res 28:322-344.
14. Lindsay DC, Anand IS, Bennett JG, Pepper JR, Yacoub MH, Rothery SM, Severs NJ, Poole-Wilson PA. (1994). Utrastructural analysis of skeletal muscle. Microvascular dimensions and basement membrane thickness in chronic heart failure. Eur Heart J 15:1470-1476.
15. Mahy IR, Shore AC, Smith LD, Tooke JE. (1995). Disturbance of peripheral microvascular function in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Cardiovasc Res 30:939-944.
16. Reed RK, Ishibashi M, Townsley MI, Parker JC, Taylor AE. (1993). Blood-to-tissue clearance vs. lymph analysis in determining capillary transport characteristics for albumin in skin. Am J Physiol 264:H1394-H1401.
17. d's s at low lymph flows. Am J Physiol 261:H728-H740.
18. Reed RK, Townsley MI, Taylor AE. (1989). Estimation of capillary reflection coefficients and unique PS products in dog paw. Am J Physiol 257:H1037-H1041.
19. Riegger GA, Liebau G, Holzschuh M, Witkowski D, Steilner H, Kochsiek K. (1984). Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade. Am J Cardiol 53:614-618.
20. Roy BJ, Pitts VH, Townsley MI. (1996). Pulmonary vascular response to angiotensin II in canine pacing-induced heart failure. Am J Physiol 271:H222-H227.
21. Rubinstein I, Muns G, Zucker IH. (1994). Plasma exudation in conscious dogs with experimental heart failure. Basic Res Cardiol 89:487-498.
22. Rutili G, Granger DN, Taylor AE, Parker JC, Mortillaro NA. (1982). Analysis of lymphatic protein data. IV. Comparison of the different methods used to estimate reflection coefficients and permeability-surface area products. Microvas Res 23:347-360.
23. 2-receptor blocking agent. Agents Actions 16:19-20.
24. Townsley MI, Fu Z, Mathieu-Costello O, West JB. (1995). Pulmonary microvascular permeability. Responses to high vascular pressure after induction of pacing-induced heart failure in dogs. Circ Res 77: 317-325.
25. Townsley MI, Pitts VH, Ardell JL, Zhao Z, Johnson WH Jr. (1994). Altered pulmonary microvascular reactivity to norepinephrine in canine pacing-induced heart failure. Circ Res 75:347-356.
26. Townsley MI, Reed RK, Ardell JL, Laurent TC. (1993). Lung, heart and skin interstitial matrix composition following development of pacing-induced heart failure. Proc XXXII Cong Int Union Physiol Sci 323.8 (Abstract).
27. Vredevoe DL, Moser DK, Gan XH, Bonavida B. (1995). Natural killer cell anergy to cytokine stimulants in a subgroup of patients with heart failure: relationship to norepinephrine. Neuroimmunomodulation 2:16-24.
28. Vredevoe DL, Woo MA, Doering LV, Brecht ML, Hamilton MA, Fonarow GC. (1998). Skin test anergy in advanced heart failure secondary to cither ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 82:323-328.